{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:02:21Z","timestamp":1781078541538,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.msard.2025.106892","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:06:35Z","timestamp":1764432395000},"page":"106892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transverse myelitis following COVID-19 infection or vaccination: Clinical outcomes and imaging characteristics compared with idiopathic cases"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-096X","authenticated-orcid":false,"given":"Ji-Yon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5074-1217","authenticated-orcid":false,"given":"Hee-Jae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-9802","authenticated-orcid":false,"given":"Shina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8047-1029","authenticated-orcid":false,"given":"Eun-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-4531","authenticated-orcid":false,"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-812X","authenticated-orcid":false,"given":"Young-Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106892_bib0001","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s13365-021-00986-w","article-title":"MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?","volume":"27","author":"Abrams","year":"2021","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.msard.2025.106892_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120463","article-title":"Transverse myelitis following COVID-19: insights from a multi-center study and systematic literature review","volume":"443","author":"Adamec","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106892_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675307","article-title":"Cerebrospinal fluid findings in 541 patients with clinically isolated syndrome and multiple sclerosis: a monocentric study","volume":"12","author":"Berek","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106892_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3988\/jcn.2022.18.1.120","article-title":"MRI negative myelitis induced by Pfizer-BioNTech COVID-19 vaccine","volume":"18","author":"Cabral","year":"2022","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2377-13-135","article-title":"Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series","volume":"13","author":"Cobo Calvo","year":"2013","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000529927","article-title":"Development of acute transverse myelitis following COVID-19 infection: a review on the potential pathways","volume":"86","author":"Farrokhi","year":"2023","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0008","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/1352458517731911","article-title":"Predictors of outcome in a large retrospective cohort of patients with transverse myelitis","volume":"24","author":"Gastaldi","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106892_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2023-001336","article-title":"Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination","volume":"8","author":"Georganta","year":"2023","journal-title":"BMJ Open. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106892_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1099758","article-title":"New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review","volume":"14","author":"Harel","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0011","first-page":"219","article-title":"Transverse myelitis as a rare neurological complication of coronavirus disease 2019: a case report and literature review","volume":"48","author":"Hooshmandi","year":"2023","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.msard.2025.106892_bib0012","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3174\/ajnr.A7256","article-title":"COVID-19-Associated Myelitis involving the dorsal and lateral white matter tracts: a case series and review of the literature","volume":"42","author":"Huang","year":"2021","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2025.106892_bib0013","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","article-title":"SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: a case report and literature review","volume":"61","author":"Ide","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.msard.2025.106892_bib0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.54299\/tmed\/jidk4591","article-title":"The modified Rankin Scale can accurately be derived from the electronic medical record","volume":"1","author":"Isenberg","year":"2022","journal-title":"Transformative Medicine"},{"key":"10.1016\/j.msard.2025.106892_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00415-021-10752-x","article-title":"Association of CNS demyelination and COVID-19 infection: an updated systematic review","volume":"269","author":"Ismail","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0016","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1007\/s00415-022-11194-9","article-title":"MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature","volume":"269","author":"Jarius","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0017","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106892_bib0018","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2025.106892_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1275696","article-title":"Case report: mRI-negative myelitis following COVID-19 with SEP abnormalities: a case series and literature review","volume":"14","author":"Kawama","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0020","first-page":"499","article-title":"Myelitis associated with COVID-19: clinical, radiological, laboratory characteristics (serum and CSF cytokines profiles)","volume":"30","author":"Kozlova","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.37349\/ei.2024.00132","article-title":"Myelitis associated with COVID-19: clinical, radiological, and laboratory characteristics","volume":"4","author":"Kozlova","year":"2024","journal-title":"Explor. Immunol."},{"key":"10.1016\/j.msard.2025.106892_bib0022","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.STR.0000119385.56094.32","article-title":"Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale","volume":"35","author":"Kwon","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.msard.2025.106892_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70020","article-title":"The association between acute transverse myelitis and COVID-19 vaccination in Korea: self-controlled case series study","volume":"32","author":"Lim","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0024","first-page":"15","article-title":"MRI-negative myelitis associated with cerebral venous thrombosis after COVID-19 infection","author":"Masaad","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.msard.2025.106892_bib0025","doi-asserted-by":"crossref","DOI":"10.3171\/CASE22244","article-title":"Transverse myelitis after Johnson & Johnson COVID-19 vaccine: illustrative case","volume":"4","author":"Mathew","year":"2022","journal-title":"J. Neurosurg. Case Lessons."},{"key":"10.1016\/j.msard.2025.106892_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106513","article-title":"Late-onset rapidly progressive MRI- negative-myelitis after COVID-19 illness","volume":"202","author":"Memon","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2025.106892_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104032","article-title":"Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: a systematic review","volume":"66","author":"Ostovan","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106892_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653786","article-title":"Acute transverse myelitis (ATM):clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222)","volume":"12","author":"Roman","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106892_bib0029","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1111\/ene.14952","article-title":"Systematic review of cases of acute myelitis in individuals with COVID-19","volume":"28","author":"Schulte","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106892_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102638","article-title":"Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder","volume":"47","author":"Sechi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106892_bib0031","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sc.2008.143","article-title":"Diagnostic workup of patients with acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings","volume":"47","author":"Sellner","year":"2009","journal-title":"Spinal Cord."},{"key":"10.1016\/j.msard.2025.106892_bib0032","first-page":"1","article-title":"Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2025.106892_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004024","article-title":"Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: a phase 3b implementation trial","volume":"19","author":"Takuva","year":"2022","journal-title":"PLoS. Med."},{"key":"10.1016\/j.msard.2025.106892_bib0034","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106892_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106892_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102324","article-title":"A case of possible atypical demyelinating event of the central nervous system following COVID-19","volume":"44","author":"Zoghi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:29:33Z","timestamp":1781076573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"alternative-id":["S2211034825006303"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106892","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transverse myelitis following COVID-19 infection or vaccination: Clinical outcomes and imaging characteristics compared with idiopathic cases","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106892"}}